他汀类药物不良反应的研究进展

被引：53

作者：

陈清杰

杨毅宁

机构：

[1] 新疆医科大学第一附属医院心脏中心冠心病科

来源：

心血管病学进展 | 2013年 / 34卷 / 02期

关键词：

他汀类药物; 不良反应; 综述;

D O I：

暂无

中图分类号：

R972 [心血管系统药物];

学科分类号：

100117 [系统生物医学];

摘要：

他汀类药物在预防动脉粥样硬化、改善预后方面已积累了大量一致的临床研究证据。总体上大多数他汀的耐受性良好,但对他汀不良反应的认识也经历了一个逐渐变化的过程。近年来对他汀类药物肌肉毒性、肝脏损害、神经系统不良反应、新发肿瘤和糖尿病等的担忧和争论始终没有停止。因此现就他汀类药物不良反应及其相关因素研究进展做一综述。

引用

页码：279 / 283

页数：5

共 9 条

[1]

Drug safety evaluation of rosuvastatin [J].

Toth, Peter P. ;

Dayspring, Thomas D. .

EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) :969-986

[2]

Are statins diabetogenic? [J].

Sampson, Uchechukwu K. ;

Linton, MacRae F. ;

Fazio, Sergio .

CURRENT OPINION IN CARDIOLOGY, 2011, 26 (04) :342-347

[3]

Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? [J].

Athyros, Vasilios G. ;

Tziomalos, Konstantinos ;

Karagiannis, Asterios ;

Wierzbicki, Anthony S. ;

Mikhailidis, Dimitri P. .

CURRENT OPINION IN CARDIOLOGY, 2010, 25 (04) :406-410

[4]

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials [J].

Sattar, Naveed ;

Preiss, David ;

Murray, Heather M. ;

Welsh, Paul ;

Buckley, Brendan M. ;

de Craen, Anton J. M. ;

Seshasai, Sreenivasa Rao Kondapally ;

McMurray, John J. ;

Freeman, Dilys J. ;

Jukema, J. Wouter ;

Macfarlane, Peter W. ;

Packard, Chris J. ;

Stott, David J. ;

Westendorp, Rudi G. ;

Shepherd, James ;

Davis, Barry R. ;

Pressel, Sara L. ;

Marchioli, Roberto ;

Marfisi, Rosa Maria ;

Maggioni, Aldo P. ;

Tavazzi, Luigi ;

Tognoni, Gianni ;

Kjekshus, John ;

Pedersen, Terje R. ;

Cook, Thomas J. ;

Gotto, Antonio M. ;

Clearfield, Michael B. ;

Downs, John R. ;

Nakamura, Haruo ;

Ohashi, Yasuo ;

Mizuno, Kyoichi ;

Ray, Kausik K. ;

Ford, Ian .

LANCET, 2010, 375 (9716) :735-742

[5]

Low-Density Lipoprotein Cholesterol Concentrations and Death Due to Intraparenchymal Hemorrhage The Ibaraki Prefectural Health Study [J].

Noda, Hiroyuki ;

Iso, Hiroyasu ;

Irie, Fujiko ;

Sairenchi, Toshimi ;

Ohtaka, Emiko ;

Doi, Mikio ;

Izumi, Yoko ;

Ohta, Hitoshi .

CIRCULATION, 2009, 119 (16) :2136-2145

[6]

Statin–Drug Interactions: Not a Class Effect.[J].William H. Frishman;John Horn.Cardiology in Review.2008, 4

[7]

The safety of statins in clinical practice [J].

Armitage, Jane .

LANCET, 2007, 370 (9601) :1781-1790

[8]

Comparative safety of Atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients [J].

Newman, C ;

Tsai, J ;

Szarek, M ;

Luo, D ;

Gibson, E .

AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (01) :61-67

[9]

Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study.[J].Eric Bruckert;Gilles Hayem;Sylvie Dejager;Caroline Yau;Bernard Bégaud.Cardiovascular Drugs and Therapy.2006, 6

← 1 →